Device Trial Radar · NCT06292494
Focused Ultrasound for Drug-resistant Epilepsy
Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Jan 1, 2024
Primary completion
Dec 31, 2027
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- Taipei Veterans General Hospital, TaiwanGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- Collaborators
- InSightec
- First posted
- Mar 5, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Focused ultrasound (FUS) has been shown to differentially lesion or modulate (excite and inhibit) brain circuit and neural activity across a broad range of acoustic stimulus parameters (intensity, duty cycle, pulse repetition frequency and pulse duration) for decades. From our previous study, FUS sonication may suppress the number of epileptic signal bursts observed in EEG recordings after the induction of acute epilepsy. The presence of the suppressive effect was found in terms of the number of epileptic EEG spikes from the analysis of the unfiltered and theta-band EEG activity, and further discontinue the seizure attacks. EEG activity has also been consistently reported to have a positive correlation with the level of epilepsy, and FUS-mediated reduction of epileptic EEG activity was most notably observed, no matter lesioning or modulating effects. The aims of this study are to demonstrate the safety and efficacy of FUS technology in epilepsy patients and to estimate the optimal parameters of focused ultrasound exposure that will be used in the case of epilepsy.
Conditions
- Focused Ultrasound
- MR-guided FUS
- Drug Refractory Epilepsy
- Drug Resistant Epilepsy
- Medication Resistant Epilepsy
Interventions
Exablate 4000 Transcranial MRgfUS SystemDevice
Focused ultrasound interrupt structure of epilepsy network to improve seizure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- pulse rate [Safety]Time frame: pre- and post- treatment immediately
- blood oxygen saturation level [Safety]Time frame: pre- and post- treatment immediately
- MRI [Safety]Time frame: pre- and post- treatment immediately
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Taipei Veterans General Hospital
Taipei, Taiwan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.